Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tulathromycin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107501364B reveals improved oxalate salt synthesis for Tulathromycin intermediates offering higher yield and milder conditions for veterinary drug manufacturing supply chains.
Patent CN103497227B reveals a mild epoxidation method for tulathromycin intermediates, offering significant supply chain stability and cost reduction benefits.